概览

September 23-24: Conference

Clinical trial disclosure continues to evolve, and clinical trial sponsors and academia must meet disclosure requirements on a global scale. Meeting these requirements is challenging, creating additional opportunities for knowledge-sharing amongst peers. This conference will feature informative sessions relating to global clinical trial disclosure and data transparency from industry experts.

While we develop our 2024 agenda, please take a moment to review the 2021 final agenda.

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.

Download Letter

Participant Testimonials

Thanks for organizing such a nice conference on CTD and Trial Transparency. It was my first experience attending the DIA conference and I learnt new initiatives taken across industry.” – Ravi Jogai, Associate Director - Syneos Health (Seasoned Clinical Research Professional)

Featured

Want to learn more about Global Clinical Trial Disclosure and Data Transparency Conference? You've come to the right site!

谁应该参加？

Conference Designed For:
- Academia
- Biometrics
- Clinical Operations / Development
- Clinical Trial Disclosure
- Clinical/Medical Research
- Compliance/Legal
- Data management
- Data transparency/data sharing
- External Health Authorities (comp and ethics committees)
- Internal Regulatory / Regulatory Submissions/Regulatory Leads
- Medical Writing, Medical Affairs, and Medical Communications
- Patient Advocacy
- Patient registries
- Publications
- Real-World Data
- Transparency policies and compliance (Clinical Data)

项目委员会

Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States
Kelly Coulbourne, MS Director, Clinical Trial Transparency and Disclosure
Pfizer Inc, United States
Scott Feiner Senior Manager, Trial Disclosure
AbbVie, United States
Francine Lane, MBA Senior Director of Product Management
Citeline, United States
Pritibha Singh, MBA, MSc Senior Manager, Corporate Affairs Analytics & Insights
Novartis AG, Switzerland
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark
Representative Invited DIA, United States